Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;30(4):2254-2255.
doi: 10.1245/s10434-022-13047-1. Epub 2023 Jan 11.

ASO Author Reflections: Active Surveillance may be Possible in Patients with T1b Papillary Thyroid Carcinoma Over 55 Years of Age Without High-Risk Features on Preoperative Examinations

Ho-Ryun Won #  1   2 , Eonju Jeon #  3 , Da Beom Heo  4 , Jae Won Chang  1   4 , Minho Shong  5   6 , Je Ryong Kim  7 , Hyemi Ko  7 , Yea Eun Kang  5 , Hyon-Seung Yi  5 , Ju Hee Lee  5 , Kyong Hye Joung  5   6 , Ji Min Kim  5   6 , Younju Lee  8 , Sung-Woo Kim  3 , Young Ju Jeong  9 , Yong Bae Ji  10 , Kyung Tae  11 , Bon Seok Koo  12   13 ; MASTER study group
Affiliations
Comment

ASO Author Reflections: Active Surveillance may be Possible in Patients with T1b Papillary Thyroid Carcinoma Over 55 Years of Age Without High-Risk Features on Preoperative Examinations

Ho-Ryun Won et al. Ann Surg Oncol. 2023 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133. - DOI - PubMed - PMC
    1. Sakai T, Sugitani I, Ebina A, et al. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma. Thyroid. 2019;29(1):59–63. - DOI - PubMed
    1. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient Age is Significantly Related to the Progression of Papillary Microcarcinoma of the Thyroid Under Observation. Thyroid. 2014;24(1):27–34. - DOI - PubMed - PMC
    1. Lee EK, Kang YE, Park YJ, et al. A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol. Endocrinol Metab (Seoul). 2021;36(3):574–81. - DOI - PubMed - PMC
    1. Won HR, Jeon E, Heo DB, et al. Age-dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-13011-z . - DOI - PubMed

LinkOut - more resources